From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Hemogenyx shares soar 117% after two tweets - is this the new RNS? Surely this is a bit naughty

By Tom Winnifrith | Monday 26 February 2018


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Is @HemoGenyx the corporate account of HemoGenyx (HEMO)? Sadly PR poltroon Paul "Queenie" McManus of Walbrook and pouting brokerette Lucy Williams of Peterhouse have yet to return my calls as I pose this question. But since the lamentable Walbrook has tweeted directed to @HemoGenyx in the past they are either complete idiots (well they are) or that is all the confirmation one needs. Which makes the last two tweets on this account all the more outrageous. You can see them below. Bear in mind there has been no supporting RNS.

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Ariana – Surprise!

Time left: 20:41:11